2Hossmann V,Heiss WD,Bewermeyer H,et al. Controlled trial of ancrod in ischemic stroke:what is the next step.Arch Neurol, 1983,40:803-808.
3Dempfle CE,Alesci S,Kucher K,et al. Plasminogen activation without changes in t-PA and PAI-1 in response to subcutaneous administration of ancrod.Thromb Res,2001,104:433-438.
4Samsa GP,Matcher DB,Williams GR,et al.Cost-effectiveness of ancrod treatment of acute ischaemic stroke:results from the stroke treatment with ancrod trial. J Eval Clin Pract,2002,8:61-70.
5Sherman DG.Antithrombotic therapy in the acute phase:new approaches. Cerebrovasc Dis,2001,11:49-54.
6Bogousslavsky J,Paciaroni M,Gallai V,et al.Glycoprotein Ⅱ b/Ⅲ a inhibitors for acute stroke treatment. Clin Exp Hypertens,2002,24:603-610.
7Lee DH,Jo KD,Kim HG,et al. Local intraarterial urokinase thrombolysis of acute ischemic stroke with or without intravenous abciximab:a pilot study.J Vasc Interv Radiol,2002,13:769-774.
8Eckert B,Koch C,Thomalla G,et al. Acute basilar artery occlusion treated with combined intravenuos abciximab and intra-arterial tissue plasminogen active. Stroke,2002,33:1424-1427.
9Hofmann R,Kerschner K,Steinwender C,et al. Abciximab bolus injection does not reduce cerebral ischemic complications of elective carotid artery stenting. Stroke,2002,33:725-727.
10Morris D,Fomann R,Kender G,et al.Treatment of acute stroke with rt-PA and abciximab. Acad Emerg Med,2003,10:1396-1399.
3Sousa RM, Ferri CP, Acosta D, et al. The contribution of chronic diseases to the prevalence of dependence among older people in Latin America, China and India: a 10/65 Dementia Research Group population-based survey. BMC Geriatr, 2010,10:53.
4Charlot M, Ahlehoff O, Norgaard ML, et al. Proton-pump inhibitors are associated with increased cardiovascular risk independent of clopidogrel use: a nationwide cohort study. Ann Intern Med,2010,153(6) :378-386.
5Bruzzi P, Green SB , Byar DP, et al. Estimating the population attributable risk for multiple risk factors using ease-control data. Am J Epidemiol,1985,122(5): 904-913.
6Coughlin SS, Nass CC, Pickle LW, et al. Regression methods for estimating attributable risk in population based casecontrol studies: a comparison of additive and multiplicative models. Am J Epidemiol,1991,133(3) :305-311.
